Abstract
The nuclear transcription factor peroxisome proliferator-activated receptor (PPAR) γ plays a central role in normal lung development. However, the effects of modulating PPARγ expression by exogenously administered PPARγ agonists on lung development and basic blood biochemical and metabolic profiles in a developing animal are not known. To determine these effects, newborn Sprague-Dawley rat pups were administered either diluent or rosiglitazone (RGZ), a potent PPARγ agonist, for either 1 or 7 d. Then the pups were killed and the lungs were examined for specific markers of alveolar epithelial, mesenchymal, and vascular maturation, and lung morphometry. The effect of RGZ on a limited number of blood biochemical and metabolic parameters was also determined. Overall, systemically administered RGZ significantly enhanced lung maturation without affecting serum electrolytes, blood glucose, blood gases, plasma cholesterol, triglycerides, and serum cardiac troponin levels. The lung maturation effect of PPARγ agonists was also confirmed by another PPARγ agonist, the naturally occurring PPARγ ligand prostaglandin J2. We conclude that systemically administered RGZ significantly enhances lung maturation without significantly affecting the acute blood biochemical and metabolic profiles, providing rationale for further studying PPARγ agonists for enhancing lung maturation, and for promoting lung injury/repair in neonates.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- ADRP:
-
adipocyte differentiation-related protein
- ATII:
-
alveolar type 2
- PPARγ:
-
peroxisome proliferator-activated receptor gamma
- PGJ2:
-
prostaglandin J2
- PTHrP:
-
parathyroid hormone-related protein
- RGZ:
-
rosiglitazone
- SP:
-
surfactant protein
References
Tontonoz P, Hu E, Spiegelman BM 1995 Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev 5: 571–576
Chen H, Jackson S, Doro M, McGowan S 1998 Perinatal expression of genes that may participate in lipid metabolism by lipid-laden lung fibroblasts. J Lipid Res 39: 2483–2492
Torday JS, Torres E, Rehan VK 2003 The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro. Pediatr Pathol Mol Med 22: 189–207
Simon DM, Arikan MC, Srisuma S, Bhattacharya S, Tsai LW, Ingenito EP, Gonzalez F, Shapiro SD, Mariani TJ 2006 Epithelial cell PPAR[gamma] contributes to normal lung maturation. FASEB J 20: 1507–1509
1995 Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA 273: 413–418
Wapner RJ, Sorokin Y, Mele L, Johnson F, Dudley DJ, Spong CY, Peaceman AM, Leveno KJ, Malone F, Caritis SN, Mercer B, Harper M, Rouse DJ, Thorp JM, Ramin S, Carpenter MW, Gabbe SG, National Institute of Child Health and Human Development Maternal-Fetal Medicine Unite Network 2007 Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med 357: 1190–1198
Ballard PL, Ballard RA, Granberg JP, Sniderman S, Gluckman PD, Kaplan SL, Grumbach MM 1980 Fetal sex and prenatal betamethasone therapy. J Pediatr 97: 451–454
Nielson HC, Torday JS 2000 Sex differences in fetal lung development: Biology, Etiology, and Evolutionary Significance. In: Mendelson CR (ed) Endocrinology of the Lung-Development and Surfactant Synthesis. Totowa, New Jersey: Humana Press, pp 141–159
Willet KE, Jobe AH, Ikegami M, Newnham J, Sly PD 2000 Antenatal retinioic acid does not alter alveolization or postnatal lung function in preterm sheep. Eur Respir J 16: 101–107
Srinivasan G, Bruce EN, Houtz PK, Bruce MC 2002 Dexamethasone-induced changes in lung function are not prevented by concomitant treatment with retinoic acid. Am J Physiol Lung Cell Mol Physiol 283: L275–L287
Rehan VK, Wang Y, Sugano S, Santos J, Patel S, Sakurai R, Boros LG, Lee WP, Torday JS 2007 In utero nicotine exposure alters fetal rat lung alveolar type II cell proliferation, differentiation, and metabolism. Am J Physiol Lung Cell Mol Physiol 292: L323–L333
Randell SH, Mercer RR, Young SL 1989 Postnatal growth of pulmonary acini and alveoli in normal and oxygen-exposed rats studied by serial section reconstructions. Am J Anat 186: 55–68
Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A 1996 Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435–439
Massaro D, Massaro GD 1986 Dexamethasone accelerates postnatal alveolar wall thinning and alters wall composition. Am J Physiol 251: R218–R224
Massaro D, Teich N, Maxwell S, Massaro GD, Whitney P 1985 Postnatal development of alveoli. Regulation and evidence for a critical period in rats. J Clin Invest 76: 1297–1305
Cerny L, Torday JS, Rehan VK 2008 Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook. Lung 186: 75–89
Heikkinen S, Auwerx J, Argmann CA 2007 PPARgamma in human and mouse physiology. Biochim Biophys Acta 1771: 999–1013
Rehan VK, Sugano S, Wang Y, Santos J, Romero S, Dasgupta C, Keane MP, Stahlman MT, Torday JS 2006 Evidence for the presence of lipofibroblasts in human lung. Exp Lung Res 32: 379–393
Torday JS, Rehan VK 2007 Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res 62: 2–7
Standiford TJ, Keshamouni VG, Reddy RC 2005 Peroxisome proliferator-activated receptor-{gamma} as a regulator of lung inflammation and repair. Proc Am Thorac Soc 2: 226–231
Torday JS, Rehan VK 2002 Stretch-stimulated surfactant synthesis is coordinated by the paracrine actions of PTHrP and leptin. Am J Physiol Lung Cell Mol Physiol 283: L130–L135
Liu D, Zeng BX, Zhang SH, Yao SL 2005 Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia. Inflamm Res 54: 464–470
Rehan VK, Wang Y, Patel S, Santos J, Torday JS 2006 Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo. Pediatr Pulmonol 41: 558–569
Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatterjee PK, Thiemermann C 2002 Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J 16: 1027–1040
Genovese T, Cuzzocrea S, Di Paola R, Mazzon E, Mastruzzo C, Catalano P, Sortino M, Crimi N, Caputi AP, Thiemermann C, Vancheri C 2005 Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. Eur Respir J 25: 225–234
Khan MA, St Peter JV, Xue JL 2002 A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone. Diabetes Care 25: 708–711
Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ 2007 Rosiglitazone evaluated for cardiovascular outcomes–an interim analysis. N Engl J Med 357: 28–38
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by grants from the NIH (HL075405 and HL55268) and the TRDRP (14RT-0073 and 15IT-0250).
Rights and permissions
About this article
Cite this article
Wang, Y., Santos, J., Sakurai, R. et al. Peroxisome Proliferator-Activated Receptor γ Agonists Enhance Lung Maturation in a Neonatal Rat Model. Pediatr Res 65, 150–155 (2009). https://doi.org/10.1203/PDR.0b013e3181938c40
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/PDR.0b013e3181938c40
